Kehua Bio: Real-time Fluorescence Quantitative PCR Instrument Receives Medical Device Registration Certificate

People’s Financial News, March 23 — Kewah Bio (002022) announced on March 23 that its controlling subsidiary, Xi’an Tianlong Technology Co., Ltd., received the medical device registration certificate from the National Medical Products Administration for its real-time fluorescent quantitative PCR instrument. This product is based on the real-time fluorescence PCR detection principle and is used in conjunction with matching test reagents. It is applied clinically for qualitative and quantitative detection of target nucleic acids (DNA/RNA) derived from human samples, including pathogen detection and human gene testing projects.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin